drug launches

AstraZeneca kicks off second blood cancer launch, this time for orphan drug Lumoxiti
AstraZeneca kicks off second blood cancer launch, this time for orphan drug Lumoxiti
Fierce Pharma
AstraZeneca
drug launches
Lumoxiti
hairy cell leukemia
Flag link:
Lessons From The Biggest Pharma Drug Launches Of All Time
Lessons From The Biggest Pharma Drug Launches Of All Time
Forbes
drug launches
Gilead Sciences
JNJ
Pfizer
Flag link:
Ferring launches Nocdurna in US to treat nocturia due to NP
Ferring launches Nocdurna in US to treat nocturia due to NP
Pharmaceutical Business Review
Ferring
Nocdurna
nocturnal polyuria
drug launches
Flag link:
As Novartis' other cancer launches struggle, Lutathera gets off to flying start
As Novartis' other cancer launches struggle, Lutathera gets off to flying start
Fierce Pharma
Novartis
Lutathera
drug launches
neuroendocrine tumors
Flag link:
GW announces US launch of cannabinoid medicine for seizures
GW announces US launch of cannabinoid medicine for seizures
Pharmaceutical Business Review
GW Pharma
Greenwich. Epidiolex
drug launches
Dravet syndrome
Lennox-Gastaut Syndrome
Flag link:
GW Pharma looks to dispel cannabis stigma with Epidiolex launch
GW Pharma looks to dispel cannabis stigma with Epidiolex launch
Fierce Pharma
GW Pharma
Epidiolex
drug launches
Cannabidiol
Flag link:
No sweat? Dermira snags reps, sets price and plots branded ads for Qbrexza launch
No sweat? Dermira snags reps, sets price and plots branded ads for Qbrexza launch
Fierce Pharma
Dermira
Qbrexa
drug launches
Flag link:
2 Blockbuster New Drug Launches Making Investors Nervous Right Now
2 Blockbuster New Drug Launches Making Investors Nervous Right Now
Motley Fool
drug launches
Alnylam
GW Pharma
Onpattro
Epidiolex
Flag link:
After Alnylam’s solo maiden launch, here comes the tricky bit
After Alnylam’s solo maiden launch, here comes the tricky bit
EP Vantage
Alnylam
drug launches
FDA
RNAi
Patisiran
Onpattro
Flag link:
GlaxoSmithKline boosted Shingrix educational efforts after seeing administration, storage errors in launch
GlaxoSmithKline boosted Shingrix educational efforts after seeing administration, storage errors in launch
Fierce Pharma
drug launches
GSK
Shingrix
shingles
vaccines
Flag link:
La Jolla inks royalty deal to support Giapreza launch
La Jolla inks royalty deal to support Giapreza launch
Biopharma Dive
La Jolla Pharmaceutical
HealthCare Royalty Partners
Giapreza
drug launches
shock
Flag link:
Novo Nordisk results show GLP-1s are job 1. Can its crucial Ozempic launch deliver?
Novo Nordisk results show GLP-1s are job 1. Can its crucial Ozempic launch deliver?
Fierce Pharma
Novo Nordisk
GLP-1 agonist
diabetes
Ozempic
drug launches
Flag link:
Aerie launches glaucoma drug in U.S.
Aerie launches glaucoma drug in U.S.
Drug Delivery Business News
Aerie Pharma
Rhopressa
glaucoma
ocular hypertension
drug launches
Flag link:
3 Blockbuster Drug Launches to Watch In 2018
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
Flag link:
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Fierce Pharma
drug reps
dermatology
Aclaris
Eskata
drug launches
seborrheic keratoses
Flag link:
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Flag link:
‘That’s $425,000 right there’ — the anxious launch of a gene therapy with a record sticker price
‘That’s $425,000 right there’ — the anxious launch of a gene therapy with a record sticker price
Stat
gene therapy
drug pricing
drug launches
Luxturna
Spark Therapeutics
Flag link:
Should outcomes-based pricing be the blueprint for all specialty drug launches?
Should outcomes-based pricing be the blueprint for all specialty drug launches?
Medical Marketing and Media
outcomes-based pricing
drug pricing
drug launches
specialty drugs
Flag link:
What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
Fierce Pharma
drug launches
hepatitis C
Ibrance
Tecfidera
Biogen
Pfizer
Gilead Sciences
Flag link:
BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
CP Wire
BASF
Hepaxa
DIEM Labs
non-alcoholic fatty liver disease
drug launches
Flag link:

Pages